Direct Selling Self-Regulatory Council Refers Wayal Health Product Performance Claims to the FTC for Possible Enforcement Action

McLean, VA – June 6, 2023 – The Direct Selling Self-Regulatory Council (DSSRC) of BBB National Programs has referred direct selling company Wayal Health Sciences USA, Inc. to the Federal Trade Commission (FTC) for possible enforcement action. The referral comes after Wayal Health failed to respond to a DSSRC inquiry into aggressive health-related product performance claims made on social media by the company and its salesforce members.  

DSSRC is an independent national advertising self-regulation program that monitors advertising and marketing claims in the direct selling industry. Wayal Health is a multi-level direct-selling company that markets health and wellness nutritional supplements. 

At issue are social media earnings claims indicating that Wayal Health products can treat a series of health-related conditions, such as memory loss, Alzheimers, skin cancer, and ADHD. 

DSSRC expressed its concern that such claims not only require substantiation, but in the case of health-related claims, that substantiation must come in the form of competent and reliable scientific evidence.

After multiple attempts, Wayal Health has failed to respond to DSSRC’s inquiry and, pursuant to DSSRC Policies and Procedures, has now been referred to the FTC and the Utah Office of the Attorney General for possible enforcement action. 

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of DSSRC decisions, visit the DSSRC Cases and Closures webpage.